These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 37034479)

  • 41. Glial activation positron emission tomography imaging in radiation treatment of breast cancer brain metastases.
    Badiuk SR; Thiessen JD; Maleki Vareki S; Foster PJ; Chen JZ; Wong E
    Phys Imaging Radiat Oncol; 2022 Jan; 21():115-122. PubMed ID: 35359488
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bisphosphonates and other bone agents for breast cancer.
    Wong MH; Stockler MR; Pavlakis N
    Cochrane Database Syst Rev; 2012 Feb; (2):CD003474. PubMed ID: 22336790
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Small extracellular vesicles in breast cancer brain metastasis and the prospect of clinical application.
    Luo T; Kang Y; Liu Y; Li J; Li J
    Front Bioeng Biotechnol; 2023; 11():1162089. PubMed ID: 37091342
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor-Derived Exosomal Non-Coding RNAs: The Emerging Mechanisms and Potential Clinical Applications in Breast Cancer.
    Yi Y; Wu M; Zeng H; Hu W; Zhao C; Xiong M; Lv W; Deng P; Zhang Q; Wu Y
    Front Oncol; 2021; 11():738945. PubMed ID: 34707990
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PSMA-targeted nanoparticles for specific penetration of blood-brain tumor barrier and combined therapy of brain metastases.
    Ni J; Miao T; Su M; Khan NU; Ju X; Chen H; Liu F; Han L
    J Control Release; 2021 Jan; 329():934-947. PubMed ID: 33069744
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Construction and Validation of New Nomograms to Predict Risk and Prognostic Factors of Breast Cancer Bone Metastasis in Asian Females: A Population-Based Retrospective Study.
    Deng J; Zhang D; Zhang W; Li J
    Int J Gen Med; 2021; 14():8881-8902. PubMed ID: 34866932
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genome editing and cancer: How far has research moved forward on CRISPR/Cas9?
    Mitra S; Sarker J; Mojumder A; Shibbir TB; Das R; Emran TB; Tallei TE; Nainu F; Alshahrani AM; Chidambaram K; Simal-Gandara J
    Biomed Pharmacother; 2022 Jun; 150():113011. PubMed ID: 35483191
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heterogeneity and vascular permeability of breast cancer brain metastases.
    Babak MV; Zalutsky MR; Balyasnikova IV
    Cancer Lett; 2020 Oct; 489():174-181. PubMed ID: 32561415
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy.
    Liu Z; Shi M; Ren Y; Xu H; Weng S; Ning W; Ge X; Liu L; Guo C; Duo M; Li L; Li J; Han X
    Mol Cancer; 2023 Feb; 22(1):35. PubMed ID: 36797756
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exosome-Based Nanoplatforms: The Emerging Tools for Breast Cancer Therapy.
    Liu Q; Zhang X; Zhang J
    Front Oncol; 2022; 12():898605. PubMed ID: 35574366
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain Metastases.
    Huang RSP; Haberberger J; McGregor K; Mata DA; Decker B; Hiemenz MC; Lechpammer M; Danziger N; Schiavone K; Creeden J; Graf RP; Strowd R; Lesser GJ; Razis ED; Bartsch R; Giannoudis A; Bhogal T; Lin NU; Pusztai L; Ross JS; Palmieri C; Ramkissoon SH
    Oncologist; 2021 Oct; 26(10):835-844. PubMed ID: 34105210
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dormancy in Breast Cancer, the Role of Autophagy, lncRNAs, miRNAs and Exosomes.
    Jahangiri L; Ishola T
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563661
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Changing Natural History of HER2-Positive Breast Cancer Metastatic to the Brain in the Era of New Targeted Therapies.
    Mounsey LA; Deal AM; Keith KC; Benbow JM; Shachar SS; Zagar T; Dees EC; Carey LA; Ewend MG; Anders CK
    Clin Breast Cancer; 2018 Feb; 18(1):29-37. PubMed ID: 28867445
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An exosome-related long non-coding RNAs risk model could predict survival outcomes in patients with breast cancer.
    Qiu P; Guo Q; Lin J; Pan K; Chen J; Ding M
    Sci Rep; 2022 Dec; 12(1):22322. PubMed ID: 36566321
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical relevance of loss of 11p15 in primary and metastatic breast cancer: association with loss of PRKCDBP expression in brain metastases.
    Wikman H; Sielaff-Frimpong B; Kropidlowski J; Witzel I; Milde-Langosch K; Sauter G; Westphal M; Lamszus K; Pantel K
    PLoS One; 2012; 7(10):e47537. PubMed ID: 23118876
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.
    Van Swearingen AED; Siegel MB; Deal AM; Sambade MJ; Hoyle A; Hayes DN; Jo H; Little P; Dees EC; Muss H; Jolly T; Zagar TM; Patel N; Miller CR; Parker JS; Smith JK; Fisher J; Shah N; Nabell L; Nanda R; Dillon P; Abramson V; Carey LA; Anders CK
    Breast Cancer Res Treat; 2018 Oct; 171(3):637-648. PubMed ID: 29938395
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic Delivery of Tumor Suppressor miRNAs for Breast Cancer Treatment.
    Shinde SS; Ahmed S; Malik JA; Hani U; Khanam A; Ashraf Bhat F; Ahmad Mir S; Ghazwani M; Wahab S; Haider N; Almehizia AA
    Biology (Basel); 2023 Mar; 12(3):. PubMed ID: 36979159
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Emerging ways to treat breast cancer: will promises be met?
    Samadi P; Saki S; Dermani FK; Pourjafar M; Saidijam M
    Cell Oncol (Dordr); 2018 Dec; 41(6):605-621. PubMed ID: 30259416
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CRISPR-Cas9 Technology for the Creation of Biological Avatars Capable of Modeling and Treating Pathologies: From Discovery to the Latest Improvements.
    Nasrallah A; Sulpice E; Kobaisi F; Gidrol X; Rachidi W
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429042
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Advancing Roles of Exosomes in Breast Cancer.
    Wang X; Sun C; Huang X; Li J; Fu Z; Li W; Yin Y
    Front Cell Dev Biol; 2021; 9():731062. PubMed ID: 34790660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.